Amarin Corp Plc (AMRN)

[ziploc_1]

Vascepa was NOT approved for CVD by the FDA until after a contentious and thorough Adcom was conducted by the FDA with well known cardiologists and Amarin attending ... After the hearing, the FDA then demanded that Amarin complete the very expensive R-IT study...Only upon the successful completion of the study, did the FDA drop its skepticism and approve Vascepa for CVD...and now HN is threatening to sue for invalidity of the CVD patents on the theory that Vascepa's success was "obvious" to a "person of skill in the art"?....That suit would be dead on arrival and should not be a bargaining chip for anyone in any other litigation.